144 related articles for article (PubMed ID: 15735816)
1. "ProC Global": a functional screening test that predicts recurrent venous thromboembolism.
Grand'Maison A; Bates SM; Johnston M; McRae S; Ginsberg JS
Thromb Haemost; 2005 Mar; 93(3):600-4. PubMed ID: 15735816
[TBL] [Abstract][Full Text] [Related]
2. An abnormal ProC Global test result is associated with an increased risk of venous thromboembolism independent of test sensitivity for protein C pathway abnormalities.
Toulon P; Perez P; Rapp J; Adda R
Thromb Haemost; 2007 Jul; 98(1):228-33. PubMed ID: 17598017
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of ProC Global assay in women with a history of venous thromboembolism on hormonal therapy.
Sarig G; Aberbach I; Schliamser L; Blumenfeld Z; Brenner B
Thromb Haemost; 2006 Nov; 96(5):578-83. PubMed ID: 17080213
[TBL] [Abstract][Full Text] [Related]
4. ProC global: a new automated screening assay for the evaluation of total function of the protein C system.
Dragoni F; Tormene D; Simioni P; Arcieri P; Avvisati G; Girolami A
Clin Appl Thromb Hemost; 2001 Oct; 7(4):351-5. PubMed ID: 11697723
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of the ProC global assay for protein C pathway abnormalities. clinical experience in 899 unselected patients with venous thromboembolism.
Toulon P; Adda R; Perez P
Thromb Res; 2001 Oct; 104(2):93-103. PubMed ID: 11672753
[TBL] [Abstract][Full Text] [Related]
6. Economic impact of the introduction of the ProC Global assay in the screening strategy of protein C pathway abnormalities in unselected patients with a history of venous thromboembolism.
Toulon P; Adda R; Perez P
Thromb Haemost; 2001 Aug; 86(2):720-1. PubMed ID: 11522035
[No Abstract] [Full Text] [Related]
7. Prediction of recurrent venous thromboembolism by measuring ProC Global.
Eichinger S; Hron G; Hirschl M; Bialonczyk C; Minar E; Kollars M; Kyrle PA
Thromb Haemost; 2007 Dec; 98(6):1232-6. PubMed ID: 18064319
[TBL] [Abstract][Full Text] [Related]
8. ProC Global assay in the evaluation of women with history of severe preeclampsia or HELLP syndrome.
Heilmann L; von Tempelhoff GF; Pollow K
Clin Appl Thromb Hemost; 2002 Oct; 8(4):319-24. PubMed ID: 12518722
[TBL] [Abstract][Full Text] [Related]
9. Screening for abnormalities of the protein C anticoagulant pathway using the ProC Global assay. Results of a European multicenter evaluation.
Toulon P; Halbmeyer WM; Hafner G; Schmitt Y; Randgard B; Odpadlik M; Van Den Eynden C; Wagner C
Blood Coagul Fibrinolysis; 2000 Jul; 11(5):447-54. PubMed ID: 10937806
[TBL] [Abstract][Full Text] [Related]
10. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB;
Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
[TBL] [Abstract][Full Text] [Related]
11. Pro CR global: an effective screening test for thrombophilia.
Gupta PK; Ahmed R; Kannan M; Dwivedi SN; Choudhry VP; Saxena R
Am J Hematol; 2003 Nov; 74(3):208-10. PubMed ID: 14587054
[TBL] [Abstract][Full Text] [Related]
12. Modification of the ProC Global assay using dilution of patient plasma in factor V-depleted plasma as a screening assay for factor V Leiden mutation.
Quincampoix JC; Legarff M; Rittling C; Andiva S; Toulon P
Blood Coagul Fibrinolysis; 2001 Oct; 12(7):569-76. PubMed ID: 11685046
[TBL] [Abstract][Full Text] [Related]
13. The reduced sensitivity of the ProC Global test in protein S deficient subjects reflects a reduction in the associated thrombotic risk.
Gemmati D; Serino ML; Tognazzo S; Ongaro A; Moratelli S; Gilli G; Forini E; De Mattei M; Scapoli GL
Blood Coagul Fibrinolysis; 2001 Dec; 12(8):691-7. PubMed ID: 11734670
[TBL] [Abstract][Full Text] [Related]
14. Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years.
Sonnevi K; Tchaikovski SN; Holmström M; Rosing J; Bremme K; Lärfars G
Thromb Haemost; 2011 Nov; 106(5):901-7. PubMed ID: 21947267
[TBL] [Abstract][Full Text] [Related]
15. Screening for risk factors for thrombosis using a new generation of assays developed to evaluate the functionality of the protein C anticoagulant pathway.
Toulon P; Perez P
Hematol Oncol Clin North Am; 2000 Apr; 14(2):379-89. PubMed ID: 10806561
[TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
Strandberg K; Svensson PJ; Ohlin AK
Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343
[TBL] [Abstract][Full Text] [Related]
17. ProC Global: the first functional screening assay for the complete protein C pathway.
Dati F; Hafner G; Erbes H; Prellwitz W; Kraus M; Niemann F; Noah M; Wagner C
Clin Chem; 1997 Sep; 43(9):1719-23. PubMed ID: 9299966
[TBL] [Abstract][Full Text] [Related]
18. [Clinical usefulness of global assays of the anticoagulant pathway of protein C].
Toulon P
Ann Biol Clin (Paris); 2001; 59(5):545-50. PubMed ID: 11602384
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
[TBL] [Abstract][Full Text] [Related]
20. Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years. Relationships to hormone replacement therapy.
Lowe G; Woodward M; Vessey M; Rumley A; Gough P; Daly E
Thromb Haemost; 2000 Apr; 83(4):530-5. PubMed ID: 10780311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]